Natriuretic Peptides and Cardiac Hypertrophy* * Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 48, Issue 3, 2006, Pages 506-507

  London, Barry ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCINEURIN; ENDOTHELIN 1; NATRIURETIC FACTOR; NESIRITIDE; POLYNUCLEOTIDE;

ADRENERGIC SYSTEM; AMINO TERMINAL SEQUENCE; CARDIOVASCULAR RISK; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; KNOCKOUT MOUSE; MICROSATELLITE MARKER; NONHUMAN; NUCLEOTIDE REPEAT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METABOLISM; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TRANSGENIC MOUSE;

ANIMALS; CARDIOMEGALY; GUANYLATE CYCLASE; HUMANS; HYPERTENSION; NATRIURETIC PEPTIDES; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, ATRIAL NATRIURETIC FACTOR;

EID: 33746192644     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.020     Document Type: Editorial

References (27)

1. Lorell B.H., and Carabello B.A. Left ventricular hypertrophy. pathogenesis, detection, and prognosis. Circulation 102 (2000) 470-479
2. Frey N., Katsus H.A., Olson E.N., and Hill J.A. Hypertrophy of the heart. a new therapeutic target?. Circulation 109 (2004) 1580-1589
3. Swan L., Birnie D.H., Padmanabhan S., Inglis G., Connell J.M.C., and Hillis W.S. The genetic determination of left ventricular mass in healthy adults. Eur Heart J 24 (2003) 577-582
4. Nunez D.J.R., Clifford C.P., Al-Mahdawi S., and Dutka D. Hypertensive cardiac hypertrophy. is genetic variance the missing link?. Br J Clin Pharmacol 42 (1996) 107-117
5. Verhaaren H.A., Schieken R.M., Mosteller M., Hewitt J.K., Eaves L.J., and Nance W.E. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Wisconsin twin study). Am J Cardiol 68 (1991) 661-668
6. McMurray J., and Pfeffer M.A. New therapeutic options in congestive heart failure. part I. Circulation 105 (2002) 2099-2106
7. Molkentin J.D., Lu J.R., Antos C.L., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 (1998) 215-228
8. Diet F., Graf C., Mahnke N., et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes. Eur J Clin Invest 31 (2001) 836-842
9. Hamon M., Amant C., Bauters C., et al. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart 77 (1997) 502-505
10. Silberbach M., and Roberts Jr. C.T. Natriuretic peptide signaling. molecular and cellular pathways to growth regulation. Cell Signal 13 (2001) 221-231
11. Rubattu S., and Volpe M. The atrial natriuretic peptide. a changing view. J Hypertens 19 (2001) 1923-1931
12. Colucci W.S., Elkayam U., Horton D.P., et al., Nesiritide Study Group. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 343 (2000) 246-253
13. Topol E.J. Nesiritide-not verified. N Engl J Med 353 (2005) 113-116
14. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., and Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35 (2000) 19-24
15. Ye P., and West M.J. Cosegregation analysis of natriuretic peptide genes and blood pressure in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 30 (2003) 930-936
16. John S.W.M., Krege J.H., Oliver P.M., et al. Genetic decreases in atrial natriuretic peptide and salt sensitive hypertension. Science 267 (1995) 679-681
17. Klinger J.R., Petit R.D., Curtin L.A., et al. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol 75 (1993) 198-205
18. Oliver P.M., Fox J.E., Kim R., et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A 94 (1997) 14730-14735
19. Kishimoto I., Rossi K., and Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci U S A 98 (2001) 2703-2706
20. Holtwick R., van Eickels M., Skryabin B.V., et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111 (2003) 1399-1407
21. Sadoshima J., and Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73 (1993) 413-423
22. Rubattu S., Stanzione R., Di Angelantonio E., et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 35 (2004) 814-818
23. Kato N., Sugiyama T., Morita H., et al. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci 98 (2000) 251-258
24. Nannipieri M., Manganiello M., Pezzatini A., De Bellis A., Seghieri G., and Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 37 (2001) 1416-1422
25. Nakayama T., Soma M., Takahashi Y., Rehemudula D., Kanmatsuse K., and Furuya K. Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 86 (2000) 841-845
26. Rubattu S., Bigatti G., Evangelista A., et al. Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48 (2006) 499-505
27. Sarzani R., Dessi-Fulgheri P., Salvi F., et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 17 (1999) 1301-1305